Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Dec. 2025,
Gabelli Healthcare & WellnessRx Trust paid$3.63 Mil more to buy back shares than it received from issuing new shares.
It received$0.00 Mil from issuing more debt.
It received$37.44 Mil more from issuing preferred shares than it paid to buy back preferred shares.
It spent$5.18 Mil paying cash dividends to shareholders.
It spent$0.05 Mil on other financial activities.
In all, Gabelli Healthcare & WellnessRx Trustearned$28.58 Mil on financial activities for the
six
months ended in Dec. 2025.
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Gabelli Healthcare & WellnessRx Trust's issuance of stock for the
six
months ended in Dec. 2025 was $0.00 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Gabelli Healthcare & WellnessRx Trust's repurchase of stock for the
six
months ended in Dec. 2025 was $-3.63 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Gabelli Healthcare & WellnessRx Trust's net issuance of debt for the
six
months ended in Dec. 2025 was $0.00 Mil.
Gabelli Healthcare & WellnessRx Trust received$0.00 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Gabelli Healthcare & WellnessRx Trust's net issuance of preferred for the
six
months ended in Dec. 2025 was $37.44 Mil.
Gabelli Healthcare & WellnessRx Trust received$37.44 Mil more from issuing preferred shares than it paid to buy back preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Gabelli Healthcare & WellnessRx Trust's cash flow for dividends for the
six
months ended in Dec. 2025 was $-5.18 Mil.
Gabelli Healthcare & WellnessRx Trust spent$5.18 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Gabelli Healthcare & WellnessRx Trust's other financing for the
six
months ended in Dec. 2025 was $-0.05 Mil.
Gabelli Healthcare & WellnessRx Trust spent$0.05 Mil on other financial activities.
Gabelli Healthcare & WellnessRx Trust Cash Flow from Financing Related Terms
Gabelli Healthcare & WellnessRx Trust Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gabelli Healthcare & WellnessRx Trust Cash Flow from Financing Chart
Gabelli Healthcare & WellnessRx Trust Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $2.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of $2.11 Mil mean?
Gabelli Healthcare & WellnessRx Trust (GRX) has a Cash Flow from Financing of $2.11 Mil as of Dec. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Gabelli Healthcare & WellnessRx Trust and its competitors.
Is Gabelli Healthcare & WellnessRx Trust's Cash Flow from Financing too high?
Gabelli Healthcare & WellnessRx Trust's current Cash Flow from Financing is $2.11 Mil. Overall, Gabelli Healthcare & WellnessRx Trust has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Gabelli Healthcare & WellnessRx Trust's Cash Flow from Financing compare to WHF and MPA?
Gabelli Healthcare & WellnessRx Trust's Cash Flow from Financing of $2.11 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for an Asset Management company?
A good Cash Flow from Financing depends on the Asset Management industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Gabelli Healthcare & WellnessRx Trust and its competitors. Gabelli Healthcare & WellnessRx Trust's current Cash Flow from Financing is $2.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gabelli Healthcare & WellnessRx Trust stock overvalued right now?
Gabelli Healthcare & WellnessRx Trust (GRX) has a current Cash Flow from Financing of $2.11 Mil. The current Cash Flow from Financing is $2.11 Mil. Gabelli Healthcare & WellnessRx Trust's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Gabelli Healthcare & WellnessRx Trust (GRX), the current Cash Flow from Financing is $2.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gabelli Healthcare & WellnessRx Trust Business Description
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
35GF Score
Get the complete analysis for GRX
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRX has been successfully added to your 
